4773288007_96679a394b_b

Fast-acting mealtime insulin approved for children with diabetes in Canada

March 10, 2020
Manufacturing and Production Type 1 diabetes, diabetes, insulin, insulin pump, type 2 diabetes

Health Canada has approved Novo Nordik’s Fiasp, a faster acting mealtime insulin, for children aged 2 and above with type …

medium_ab

Alligator Bioscience hires Chief Financial Officer in interim capacity

March 9, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alligator Bioscience, pharma

Andreas Johannesson has been announced as Alligator Bioscience’s new interim Chief Financial Officer (CFO), replacing ex-CFO Per-Olof Schrewelius who it …

lars_nieba-web-image_0

Dr Lars Nieba appointed interim Chief Executive Officer at Nordic Nanovector

March 9, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Nordic Nanovector has appointed Dr Lars Nieba as the interim Chief Executive Officer. He is currently the company’s Chief Technology …

chris-thatcher-headshot_750xx1602-2136-155-0_1

Chris Thatcher to step down as President and CEO of Neuronetics

March 9, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Neuronetics, Inc and Chris Thatcher, the President and CEO, have mutually agreed that he will step down from his positions …

cambridge_skyline

Biogen and Takeda forced to send employees home as coronavirus hits Massachusetts

March 9, 2020
Manufacturing and Production, Medical Communications Biogen, Takeda, coronavirus, pharma

Big pharma has been hit by the coronavirus (COVID-19) outbreak right on its doorstep, as two of the biggest names …

22087308493_cedb177b53_b

ACC.20 cancelled due to coronavirus fears

March 9, 2020
Manufacturing and Production, Medical Communications cardio, cardiology, cardiovascular

The American College of Cardiology has cancelled its upcoming ACC.20 event with the World Congress of Cardiology due to concerns …

what-is-pharmacovigilance-328154

The need for evolution in pharmacovigilance

March 9, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, pharma, pharmacovigilance

Pharmacovigilance is a critical function in ensuring public health, but is our current system built to tackle the challenges of …

palace-westminster-bridge-city

UK Government outlines emergency measures to tackle coronavirus

March 9, 2020
Sales and Marketing British Coronavirus, Chinese Coronavirus, Wuhan Coronavirus, coronavirus

The British Government has outlined its emergency legislation to tackle coronavirus in which people could leave work to become volunteers …

FDA authorises first therapy to tackle cortisol overproduction in Cushing’s disease

March 9, 2020
Sales and Marketing Cushing's disease, FDA, pharma

The FDA has moved to approve its first therapy to directly treat the overproduction of the hormone cortisol which is …

Coronavirus forcing Eli Lilly employees to work from home

March 9, 2020
Sales and Marketing Chinese Coroanvirus, Eli Lilly, Eli Lilly Coronavirus, Wuhan Coronavirus, coronavirus

Eli Lilly is asking some of its employees to work from home to stop the spread of coronavirus on its …

20181130-niaid-hiv-test

Uganda finalising clinical trials on new injectable HIV drug

March 9, 2020
Sales and Marketing AIDS, HIV, Uganda HIV, Uganda HIV/AIDS, uganda

Uganda is preparing to enter the final stages of developing a new HIV treatment to reduce stigma and discrimination of …

nice_new_london_office_internal_3_web

NICE shoots down Dupixent for severe asthma

March 9, 2020
Sales and Marketing Dupixent, NHS, NICE, Regeneron, Sanofi, UK, asthma

NICE, the NHS’ drug watchdog in England and Wales, has announced its decision not to recommend Sanofi and Regeneron’s IL-4 …

shutterstock

Scorpion venom added to CAR-T therapy increases efficacy in brain cancer, research shows

March 6, 2020
Medical Communications, Research and Development CAR-T, Cancer, brain cancer, glioblastoma, pharma

Chimeric antigen receptor T cell (CAR-T) therapy has gained much traction and attention in the past years for its innovative …

mental-3436232_1280

Lack of mental health treatment available for HIV patients in the UK

March 6, 2020
Medical Communications AIDS, HIV, HIV AIDS, HIV treatment, HIV/AIDS

A cross-party group of MPs have said that those with HIV do not have access to adequate mental health treatment. …

az_logo

Phase 3 failure for AstraZeneca’s Imfinzi combo in unresectable metastatic bladder cancer

March 6, 2020
Medical Communications, Research and Development AstraZeneca, Cancer, Imfinzi, bladder cancer, pharma, trial failure

New Phase 3 has been released by AstraZeneca, showing that the PD-L1 inhibitor Imfinzi (durvalumab), when combined with tremelimumab, failed …

medications-money-cure-tablets

Indian regulators approve first drug for patients with NASH

March 6, 2020
Medical Communications FDA Approval, India, Indian Pharma, drug approval

The Drug Controller General of India (DCGI) has approved the marketing application for Zydus Cadila’s saroglitazar to treat patients with …

shutterstock_138095450

New study calculates median drug development costs at circa $1 billion

March 5, 2020
Manufacturing and Production, Research and Development, Sales and Marketing drug development, drug prices, pharma

New research has pinned a concrete figure on the perennial industry question: how much does it cost to bring a …

transportation_isolation_system_1

UK cases of coronavirus hit 90 as health officials move into next phase of their response

March 5, 2020
Business Services Chinese Coronavirus, MERS, Sars, Wuhan Coronavirus, coronavirus

The coronavirus has continued to spread across the UK as health officials announce they have moved into the second stage …

China approves Roche’s Actemra to fight severe complications stemming from coronavirus

March 5, 2020
Sales and Marketing Actemra, China, Roche, coronavirus, pharma

China has moved to authorise Roche’s Actemra (tocilizumab) as a treatment for severe complications from contracting the COVID-19 coronavirus in …

The Gateway to Local Adoption Series

Latest content